Fig. 3From: Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetesThe heatmap show univariate correlations between reduction in TyG index and LFC after six months of liraglutide treatment in T2D patients and changes in clinical and biological parameters. Only the correlations remaining significant after Benjamini–Hochberg correction to control the false discovery rate are reported in the heatmap. Grey cells correspond to non-applicable calculationsBack to article page